New Constructs
0Comments

Buy Eli Lilly & Company (LLY) – Attractive and Safe Enough To Take Home To Mom

The risk/reward of this stock is quite compelling. Downside risk is low as the valuation already implies a permanent 54% decline in profits. How much worse can the valuation get? Upside reward potential is strong as the stock has to go over $77/share to trade at a value that implies the company’s profits will experience a 0% decline, still a no-growth scenario.
by David Trainer, Founder & CEO
New Constructs
3Comments

Stock Pick of the Week: Buy Discover Financial Services (DFS)- Very Attractive Rating

HIDDEN GEMS: 1. Our dis­counted cash flow analy­sis shows that DFS’s cur­rent val­u­a­tion (stock price of $21.80) implies that the company’s prof­its will decline by 40% and never grow again. 2. Eco­nomic earn­ings are growing faster that reported accounting earnings. 3. Free cash flow of $2.8bn or 24% of its enterprise value during the last fiscal year.
by David Trainer, Founder & CEO
New Constructs
0Comments

Stock Pick of the Week: Buy Analog Devices Inc (ADI) – Very Attractive Rating

HIDDEN GEMS: 1. About $15 million in non-operating expenses (after-tax) cause reported earnings to be understated. 2. Our dis­counted cash flow analy­sis shows that ADI’s cur­rent val­u­a­tion (stock price of $37.18) implies that the company’s prof­its will decline by 10% and never grow again. 3. The com­pany grew its eco­nomic earn­ings by $283mm dur­ing its last fis­cal year. 4. Excess cash of $2,462.5mm or nearly 25% of its market cap
by David Trainer, Founder & CEO
New Constructs
0Comments

Buy The Travelers Co (TRV) – Very Attractive Rating

HIDDEN GEMS: 1. About $29 million in non-operating expenses (after-tax) cause reported earnings to be understated. 2. Our dis¬counted cash flow analy¬sis shows that TRV’s cur¬rent val¬u¬a¬tion (stock price of $55.49) implies that the company’s profits will decline by 30% and never grow again. 3. The company grew its economic earn¬ings by $827mm during its last fiscal year.
by David Trainer, Founder & CEO
New Constructs
1Comments

Stock Pick of the Week: Buy Colgate-Palmolive Co (CL) – Very Attractive Rating

HIDDEN GEMS: 1. About $250 million in non-operating expenses (after-tax) cause reported earnings to be understated during the last fiscal year. 2. Our discounted cash flow analysis shows that CL’s current valuation (stock price of $77.52) implies that the company’s profits will decline by 7% and never grow again. 3. The company grew its economic earnings by $229mm (14% increase) during its last fiscal year.
by David Trainer, Founder & CEO
New Constructs
0Comments

Stock Pick of the Week: Buy Bristol Myers Squibb Co (BMY) – Very Attractive Rating

HIDDEN GEMS: 1. Our dis­counted cash flow analy­sis shows that BMY’s cur­rent val­u­a­tion (stock price of $27.16) implies that the company’s prof­its will decline by 35% and never grow again. 2. The com­pany grew its eco­nomic earn­ings by $307.5mm (12% increase) dur­ing its last fis­cal year. 3. The com­pany has $9,507mm in Excess Cash, which we remove from our Invested Cap­i­tal cal­cu­la­tion. $9,507mm mil­lion is more than 20% of BMY’s market cap.
by David Trainer, Founder & CEO